Michael J. Pederson
Corporate Officer/Principal chez Abbott Ltd.
Fortune : 7 M $ au 30/04/2024
Profil
Michael J.
Pederson is currently working as a Finance Manager-Licensing & Acquisitions at Abbott Ltd.
Prior to this, he worked as the Chief Executive Officer at Vytronus, Inc. and as an Independent Director at EPIX Therapeutics, Inc.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ABBOTT LABORATORIES
0,00% | 28/02/2023 | 63 231 ( 0,00% ) | 7 M $ | 30/04/2024 |
Postes actifs de Michael J. Pederson
Sociétés | Poste | Début |
---|---|---|
Abbott Ltd. | Corporate Officer/Principal | - |
Anciens postes connus de Michael J. Pederson
Sociétés | Poste | Fin |
---|---|---|
Vytronus, Inc.
Vytronus, Inc. Medical SpecialtiesHealth Technology VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA. | Directeur Général | 06/04/2015 |
EPIX Therapeutics, Inc.
EPIX Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Vytronus, Inc.
Vytronus, Inc. Medical SpecialtiesHealth Technology VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
EPIX Therapeutics, Inc.
EPIX Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA. | Electronic Technology |
Abbott Ltd. |